SINGAPORE, Feb. 6, 2024 /PRNewswire/ — Rider Dome, a Singapore-based company specializing in AI-driven safety solution for motorcycle fleets and riders, announces the successful completion of a $2.3 million seed funding round. Participating in the funding round were private angel investors, Goldbell, a prominent Singaporean venture capital firm specializing in mobility, and Radha Rani Holdings Family… Continue reading Rider Dome Secures $2.3 Million in Seed Funding to Revolutionize Motorcycle Safety with AI-Based Solution
Category: Newswire
Saudi Arabian company SAAK International, a leading manufacturer of high-tech, industrial and defense electronics, is digitally transforming its production process with the help of Rockwell Automation
SAAK aims to fulfil its goal of localization and follow the Saudi Vision 2030 by improving its operational and production-line efficiency using the Plex MES solution AL-KHOBAR, Saudi Arabia, Feb. 6, 2024 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced that it has closed… Continue reading Saudi Arabian company SAAK International, a leading manufacturer of high-tech, industrial and defense electronics, is digitally transforming its production process with the help of Rockwell Automation
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth – Technavio
NEW YORK, Feb. 7, 2024 /PRNewswire/ — The Biologic Therapeutics Market report has been added to Technavio’s offering. The biologic therapeutics market is estimated to grow by USD 286.12 billion during 2022-2027, growing at a CAGR of 11.34%. North America is poised to lead the global biologic therapeutics market, contributing 57% to its growth during the forecast period. Key factors… Continue reading Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth – Technavio
MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication
STOCKHOLM, Feb. 7, 2024 /PRNewswire/ — Moberg Pharma ABs (OMX: MOB) marker partner in Sweden – Allderma AB, a company which specialises in the sale of over-the-counter (OTC) pharmaceuticals – has now launched sales of MOB-015 under the Terclara® brand. The interest among pharmacies has been significant for Moberg Pharma’s medication against nail fungus. ” t… Continue reading MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication
Azbil Corporation Awarded Frost & Sullivan’s Southeast Asia Company of the Year Award for Delivering Groundbreaking Smart Building Solutions that Enhance Efficiency and Operational Performance
Azbil Corporation (Azbil) provides a thorough building automation solution portfolio to cover the entire building life cycle, ensure sustainable operations, and increase the long-term asset value. SAN ANTONIO, Feb. 7, 2024 /PRNewswire/ — Frost & Sullivan recently researched the smart buildings solutions industry and, based on its findings, recognizes Azbil with the 2023 Southeast Asia Company of the… Continue reading Azbil Corporation Awarded Frost & Sullivan’s Southeast Asia Company of the Year Award for Delivering Groundbreaking Smart Building Solutions that Enhance Efficiency and Operational Performance
MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication
STOCKHOLM, Feb. 7, 2024 /PRNewswire/ — Moberg Pharma ABs (OMX: MOB) marker partner in Sweden – Allderma AB, a company which specialises in the sale of over-the-counter (OTC) pharmaceuticals – has now launched sales of MOB-015 under the Terclara® brand. The interest among pharmacies has been significant for Moberg Pharma’s medication against nail fungus. ” t… Continue reading MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication
Kindred Group appoints Nils Andén as permanent CEO
SLIEMA, Malta, Feb. 7, 2024 /PRNewswire/ — Kindred Group’s Board of Directors has decided to appoint Nils Andén as permanent CEO with immediate effect after holding the interim position since May 2023. Kindred Group plc (Kindred) announces that Nils Andén has been appointed permanent CEO by the Board of Directors and enters the position with immediate effect.… Continue reading Kindred Group appoints Nils Andén as permanent CEO
Kindred Group plc – Full-year report: January – December 2023 (unaudited)
SLIEMA, Malta, Feb. 7, 2024 /PRNewswire/ — Strong performance across select markets enabled delivery on annual target Kindred Group plc – Full-year report: January – December 2023 (unaudited) Fourth quarter 2023 Total revenue was GBP 312.9 (305.5) million, an increase of 2 per cent. Gross winnings revenue (B2C) increased by 2 per cent to GBP… Continue reading Kindred Group plc – Full-year report: January – December 2023 (unaudited)
icotec Medical nombra a Christoph Eigenmann como nuevo consejero delegado en Estados Unidos
– icotec Medical nombra a Christoph Eigenmann como nuevo consejero delegado en Estados Unidos y asciende a Carter Lonsberry a presidente ejecutivo de la junta directiva ALTSTAETTEN, Suiza y EAST HARTFORD, Conn., 7 de febrero de 2024 /PRNewswire/ — icotec ag, la empresa líder en el campo de los implantes tumorales espinales innovadores, se complace… Continue reading icotec Medical nombra a Christoph Eigenmann como nuevo consejero delegado en Estados Unidos
Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program
Redx to receive $10 million upfront; potential for up to $870 million in development, regulatory and sales milestone payments in addition to royalties on future net sales Preclinical program expands Jazz’s pipeline of targeted oncology therapies DUBLIN and ALDERLEY PARK, United Kingdom, Feb. 7, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Redx Pharma plc… Continue reading Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program